Literature DB >> 1370651

Protein-tyrosine phosphatase expression in pre-B cell NALM-6.

M Adachi1, M Sekiya, Y Arimura, M Takekawa, F Itoh, Y Hinoda, K Imai, A Yachi.   

Abstract

Protein-tyrosine phosphatase (PTP)-related complementary DNAs from NALM-6 (pre-B cell line) were amplified by reverse transcriptase polymerase chain reaction using primers corresponding to the conserved catalytic domains of PTPs. Thirty-three polymerase chain reaction products, identified as PTP related complementary DNAs, were classified to RPTP-alpha, PTP1B, and 4 novel PTPs, which were designated as BPTP-1-4. Their expressions in NALM-6 and other cell lines were confirmed by Northern blot analysis. BPTP-1 and -2 exhibited extensive homology with the first and the second catalytic domains, respectively, of leukocyte common antigen related molecule (LAR) and human PTP delta. The transcriptional sizes of BPTP-1 and BPTP-2 are the same (7.2 kilobases) as that of LAR. The expression of BPTP-1 was abundant in lymphoid cell lines TALL-1 and NALM-6 but small in colon cell line BM314, which is in sharp contrast to the expression of LAR. These data suggest that the expression levels of BPTP-1 and LAR are altered in a cell specific manner, probably making them cell type associated PTPs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370651

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  Receptor-like protein tyrosine phosphatases: alike and yet so different.

Authors:  R Schaapveld; B Wieringa; W Hendriks
Journal:  Mol Biol Rep       Date:  1997-11       Impact factor: 2.316

2.  A novel receptor-type protein tyrosine phosphatase with a single catalytic domain is specifically expressed in mouse brain.

Authors:  W Hendriks; J Schepens; C Brugman; P Zeeuwen; B Wieringa
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

Review 3.  Therapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders.

Authors:  Susan M Goebel-Goody; Matthew Baum; Constantinos D Paspalas; Stephanie M Fernandez; Niki C Carty; Pradeep Kurup; Paul J Lombroso
Journal:  Pharmacol Rev       Date:  2011-11-16       Impact factor: 25.468

Review 4.  Disruption of striatal-enriched protein tyrosine phosphatase (STEP) function in neuropsychiatric disorders.

Authors:  Takatoshi Karasawa; Paul J Lombroso
Journal:  Neurosci Res       Date:  2014-09-10       Impact factor: 3.304

5.  Association of PTP1B with Outcomes of Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy.

Authors:  Monica M Rivera Franco; Eucario Leon Rodriguez; Braulio Martinez Benitez; Luisa G Villanueva Rodriguez; Maria de la Luz Sevilla Gonzalez; Alejandra Armengol Alonso
Journal:  Breast Cancer (Auckl)       Date:  2016-11-06

6.  Protection against gamma-radiation injury by protein tyrosine phosphatase 1B.

Authors:  Marina Mojena; María Pimentel-Santillana; Adrián Povo-Retana; Victoria Fernández-García; Silvia González-Ramos; Patricia Rada; Alberto Tejedor; Daniel Rico; Paloma Martín-Sanz; Angela M Valverde; Lisardo Boscá
Journal:  Redox Biol       Date:  2018-04-21       Impact factor: 11.799

7.  Pivotal role of protein tyrosine phosphatase 1B (PTP1B) in the macrophage response to pro-inflammatory and anti-inflammatory challenge.

Authors:  P G Través; V Pardo; M Pimentel-Santillana; Á González-Rodríguez; M Mojena; D Rico; Y Montenegro; C Calés; P Martín-Sanz; A M Valverde; L Boscá
Journal:  Cell Death Dis       Date:  2014-03-13       Impact factor: 8.469

Review 8.  Past and current perspective on new therapeutic targets for Type-II diabetes.

Authors:  Pradip D Patil; Umesh B Mahajan; Kalpesh R Patil; Sandip Chaudhari; Chandragouda R Patil; Yogeeta O Agrawal; Shreesh Ojha; Sameer N Goyal
Journal:  Drug Des Devel Ther       Date:  2017-05-22       Impact factor: 4.162

9.  Gene expressions of protein tyrosine phosphatases in regenerating rat liver and rat ascites hepatoma cells.

Authors:  T Kitamura; K Nakamura; Y Mizuno; K Kikuchi
Journal:  Jpn J Cancer Res       Date:  1995-09

Review 10.  Epigenetic modification and therapeutic targets of diabetes mellitus.

Authors:  Velayutham Ravichandiran; Dipanjan Ghosh; Rajveer Singh; Shivani Chandel; Dhritiman Dey; Arijit Ghosh; Syamal Roy
Journal:  Biosci Rep       Date:  2020-09-30       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.